Zhejiang Shapuaisi Pharmaceutical Co Ltd Total Assets
Zhejiang Shapuaisi Pharmaceutical Co Ltd total assets. Based on the latest financial reports, Zhejiang Shapuaisi Pharmaceutical Co Ltd (603168) holds total assets worth CN¥2.13 Billion CNY (≈ $311.96 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see 603168 stock market capitalisation for the company's overall valuation and market capitalisation.
Total Assets of Zhejiang Shapuaisi Pharmaceutical Co Ltd (2008–2024)
Total assets of Zhejiang Shapuaisi Pharmaceutical Co Ltd from 2008 to 2024. This chart illustrates how Zhejiang Shapuaisi Pharmaceutical Co Ltd's total assets have evolved over time, based on quarterly financial data. See 603168 stock price for real-time trading data and today's change.
Zhejiang Shapuaisi Pharmaceutical Co Ltd - Asset Composition Analysis
Zhejiang Shapuaisi Pharmaceutical Co Ltd Total Assets Breakdown (December 2024)
Zhejiang Shapuaisi Pharmaceutical Co Ltd total assets breakdown as of December 2024. Zhejiang Shapuaisi Pharmaceutical Co Ltd's total assets of CN¥2.13 Billion consist of 17.4% current assets and 82.6% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 3.9% |
| Accounts Receivable | CN¥80.62 Million | 3.8% |
| Inventory | CN¥76.66 Million | 3.6% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥215.83 Million | 10.3% |
| Goodwill | CN¥332.09 Million | 15.8% |
Asset Composition Trend (2008–2024)
This chart illustrates how Zhejiang Shapuaisi Pharmaceutical Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore Zhejiang Shapuaisi Pharmaceutical Co Ltd (603168) liquidity to equity ratio to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Zhejiang Shapuaisi Pharmaceutical Co Ltd's current assets represent 17.4% of total assets in 2024, a decrease from 50.4% in 2008.
- Cash Position: Cash and equivalents constituted 3.9% of total assets in 2024, down from 4.4% in 2008.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 25.0% of total assets, an increase from 4.0% in 2008.
- Asset Diversification: The largest asset category is goodwill at 15.8% of total assets.
Zhejiang Shapuaisi Pharmaceutical Co Ltd Competitors by Total Assets
Key competitors of Zhejiang Shapuaisi Pharmaceutical Co Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Takeda Pharmaceutical Company Limited
F:TKDA
|
Germany | €15.41 Trillion |
|
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK
|
USA | $15.42 Trillion |
|
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2
|
Germany | €1.60 Trillion |
|
Ajanta Pharma Limited
NSE:AJANTPHARM
|
India | Rs56.72 Billion |
|
Changchun High & New Technology Industries Group Inc
SHE:000661
|
China | CN¥30.77 Billion |
|
Jiangsu Nhwa Pharmaceutical Co Ltd
SHE:002262
|
China | CN¥9.54 Billion |
|
Porton Fine Chemicals Ltd
SHE:300363
|
China | CN¥8.58 Billion |
|
Jubilant Pharmova Limited
NSE:JUBLPHARMA
|
India | Rs135.21 Billion |
Zhejiang Shapuaisi Pharmaceutical Co Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.16 | 1.31 | 1.79 |
| Quick Ratio | 0.83 | 1.04 | 1.63 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥56.85 Million | CN¥95.49 Million | CN¥285.73 Million |
Zhejiang Shapuaisi Pharmaceutical Co Ltd - Advanced Valuation Insights
This section examines the relationship between Zhejiang Shapuaisi Pharmaceutical Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.71 |
| Latest Market Cap to Assets Ratio | 0.13 |
| Asset Growth Rate (YoY) | -3.0% |
| Total Assets | CN¥2.11 Billion |
| Market Capitalization | $278.11 Million USD |
Valuation Analysis
Below Book Valuation: The market values Zhejiang Shapuaisi Pharmaceutical Co Ltd's assets below their book value (0.13x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: Zhejiang Shapuaisi Pharmaceutical Co Ltd's assets decreased by 3.0% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Zhejiang Shapuaisi Pharmaceutical Co Ltd (2008–2024)
The table below shows the annual total assets of Zhejiang Shapuaisi Pharmaceutical Co Ltd from 2008 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥2.11 Billion ≈ $308.21 Million |
-2.95% |
| 2023-12-31 | CN¥2.17 Billion ≈ $317.58 Million |
+10.86% |
| 2022-12-31 | CN¥1.96 Billion ≈ $286.47 Million |
+23.49% |
| 2021-12-31 | CN¥1.59 Billion ≈ $231.99 Million |
-5.23% |
| 2020-12-31 | CN¥1.67 Billion ≈ $244.80 Million |
+5.26% |
| 2019-12-31 | CN¥1.59 Billion ≈ $232.57 Million |
-3.60% |
| 2018-12-31 | CN¥1.65 Billion ≈ $241.24 Million |
-11.81% |
| 2017-12-31 | CN¥1.87 Billion ≈ $273.55 Million |
+1.48% |
| 2016-12-31 | CN¥1.84 Billion ≈ $269.56 Million |
+44.48% |
| 2015-12-31 | CN¥1.27 Billion ≈ $186.57 Million |
+46.16% |
| 2014-12-31 | CN¥872.34 Million ≈ $127.65 Million |
+45.98% |
| 2013-12-31 | CN¥597.57 Million ≈ $87.44 Million |
+15.69% |
| 2012-12-31 | CN¥516.54 Million ≈ $75.59 Million |
+57.78% |
| 2011-12-31 | CN¥327.38 Million ≈ $47.91 Million |
+47.15% |
| 2010-12-31 | CN¥222.49 Million ≈ $32.56 Million |
+19.09% |
| 2009-12-31 | CN¥186.82 Million ≈ $27.34 Million |
+14.74% |
| 2008-12-31 | CN¥162.82 Million ≈ $23.83 Million |
-- |
About Zhejiang Shapuaisi Pharmaceutical Co Ltd
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of pharmaceutical products. The company provides its products to ophthalmology, antimicrobials, gynecology, and other classes. It offers its products in injections, oral solutions, eye drops, large-volume injections, oral solutions, tablets, granules, and other dosage forms. Zhejiang Shapuaisi… Read more